# Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome

> **NCT00300872** · NA · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 140 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Continuous positive airway pressure (CPAP)
- **DEVICE:** Sham Continuous positive airway pressure (CPAP)

## Key facts

- **NCT ID:** NCT00300872
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00300872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00300872, "Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00300872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*